GELSOMINO, FRANCESCO

GELSOMINO, FRANCESCO  

Dottorandi  

Mostra records
Risultati 1 - 20 di 23 (tempo di esecuzione: 0.032 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
A phase II, open-label, single arm, trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale Andrini, Elisa; Lamberti, Giuseppe; Mazzoni, Francesca; Riccardi, Ferdinando; Bonetti, Andrea; Fo...llador, Alessandro; Artioli, Fabrizio; Genova, Carlo; Barbieri, Fausto; Frassoldati, Antonio; Brighenti, Matteo; Colantonio, Ida; Pasello, Giulia; Ficorella, Corrado; Cinieri, Saverio; Tiseo, Marcello; Gelsomino, Francesco; Tognetto, Michele; Rihawi, Karim; Ardizzoni, Andrea 2022-01-01 FUTURE ONCOLOGY - 1.01 Articolo in rivista -
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC Ruzzi, Francesca; Angelicola, Stefania; Landuzzi, Lorena; Nironi, Elena; Semprini, Maria Sofia; S...calambra, Laura; Altimari, Annalisa; Gruppioni, Elisa; Fiorentino, Michelangelo; Giunchi, Francesca; Ferracin, Manuela; Astolfi, Annalisa; Indio, Valentina; Ardizzoni, Andrea; Gelsomino, Francesco; Nanni, Patrizia; Lollini, Pier-Luigi; Palladini, Arianna 2022-01-01 TRANSLATIONAL LUNG CANCER RESEARCH - 1.01 Articolo in rivista ADK-VR2 TLCR.pdftlcr-11-11-2216-coif.zip
Genetic Characterization of Cancer of Unknown Primary Using Liquid Biopsy Approaches Laprovitera N.; Salamon I.; Gelsomino F.; Porcellini E.; Riefolo M.; Garonzi M.; Tononi P.; Valen...te S.; Sabbioni S.; Fontana F.; Manaresi N.; D'Errico A.; Pantaleo M.A.; Ardizzoni A.; Ferracin M. 2021-01-01 FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY - 1.01 Articolo in rivista 2021_Laprovitera-fcell-09-666156.pdfSupplementary Material.zip
Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes Di Federico, Alessandro; De Giglio, Andrea; Gelsomino, Francesco; De Biase, Dario; Giunchi, Franc...esca; Palladini, Arianna; Sperandi, Francesca; Melotti, Barbara; Ardizzoni, Andrea 2022-01-01 CANCERS - 1.01 Articolo in rivista cancers-14-03472-v2.pdfcancers-14-03472-s001.zip
Impact of Baseline Versus Intercurrent Steroids Administration on Upfront Chemo-Immunotherapy for Advanced Non-Small Cell Lung Cancer (NSCLC) De Giglio, Andrea; Aprile, Marta; Di Federico, Alessandro; Sperandi, Francesca; Melotti, Barbara;... Gelsomino, Francesco; Ardizzoni, Andrea 2022-01-01 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 1.01 Articolo in rivista ijms-23-10292.pdf
Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC Dall'Olio, Filippo G; Parisi, Claudia; Marcolin, Laura; Brocchi, Stefano; Caramella, Caroline; Co...nci, Nicole; Carpani, Giulia; Gelsomino, Francesco; Ardizzoni, Stefano; Marchese, Paola Valeria; Paccapelo, Alexandro; Grilli, Giada; Golfieri, Rita; Besse, Benjamin; Ardizzoni, Andrea 2022-01-01 THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY - 1.01 Articolo in rivista 12. Dall'Olio_Monitoring Tumor Growth Rate to predict Immune Checkpoint Inhibitors’ treatment outcome in advanced NSCLC.pdf
Paraneoplastic vs. non-paraneoplastic anti-Hu associated dysmotility: a case series and literature review Rossi, Simone; Merli, Elena; Rinaldi, Rita; Deleonardi, Gaia; Mastrangelo, Vincenzo; Sasdelli, An...na Simona; Di Federico, Alessandro; Guarino, Maria; Donadio, Vincenzo; Pironi, Loris; Gelsomino, Francesco; De Giorgio, Roberto; D'Angelo, Roberto 2022-01-01 JOURNAL OF NEUROLOGY - 1.01 Articolo in rivista -
Patterns of renal toxicity from the combination of pemetrexed and pembrolizumab for advanced nonsquamous non-small-cell lung cancer (NSCLC): A single-center experience De Giglio, Andrea; Grandinetti, Valeria; Aprile, Marta; Borelli, Greta; Campus, Anita; Croci Chio...cchini, Anna Laura; Busutti, Marco; Vischini, Gisella; Di Federico, Alessandro; Sperandi, Francesca; Melotti, Barbara; Ardizzoni, Andrea; La Manna, Gaetano; Gelsomino, Francesco 2022-01-01 LUNG CANCER - 1.01 Articolo in rivista DEgiglio_2023.pdf
PD-(L)1 inhibitors as single-agent or in combination with chemotherapy for advanced, PD-L1-high non-small cell lung cancer: a meta-analysis Di Federico A.; De Giglio A.; Nuvola G.; Deiana C.; Conci N.; Gelsomino F.; Ardizzoni A. 2021-01-01 FUTURE ONCOLOGY - 1.01 Articolo in rivista -
PD-1/PD-L1 inhibitor monotherapy or in combination with chemotherapy as upfront treatment for advanced NSCLC with PD-L1 expression ≥ 50%: Selecting the best strategy Di Federico A.; De Giglio A.; Parisi C.; Gelsomino F.; Ardizzoni A. 2021-01-01 CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY - 1.01 Articolo in rivista -
PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non–small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors Dall'Olio F.G.; Gelsomino F.; Conci N.; Marcolin L.; De Giglio A.; Grilli G.; Sperandi F.; Fontan...a F.; Terracciano M.; Fragomeno B.; Tober N.; Manferrari G.; Brocchi S.; Golfieri R.; Fiorentino M.; Ardizzoni A. 2021-01-01 CLINICAL LUNG CANCER - 1.01 Articolo in rivista -
PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors Minari R.; Bonatti F.; Mazzaschi G.; Dodi A.; Facchinetti F.; Gelsomino F.; Cinquegrani G.; Squad...rilli A.; Bordi P.; Buti S.; Bersanelli M.; Leonetti A.; Cosenza A.; Ferri L.; Rapacchi E.; Quaini F.; Ardizzoni A.; Tiseo M. 2021-01-01 TUMORI - 1.01 Articolo in rivista -
PD-L1 ≥ 50% lung cancer refractory to PD-1 inhibition: The role of salvage chemo-immunotherapy combination Gelsomino F.; Facchinetti F.; Sisi M.; Zielli T.; Tiseo M.; Ardizzoni A. 2021-01-01 IMMUNOTHERAPY - 1.01 Articolo in rivista -
Predictors of Survival to Immunotherapy and Chemoimmunotherapy in Non-Small Cell Lung Cancer: A Meta-Analysis Di Federico, Alessandro; De Giglio, Andrea; Gelsomino, Francesco; Sperandi, Francesca; Melotti, B...arbara; Ardizzoni, Andrea 2022-01-01 JOURNAL OF THE NATIONAL CANCER INSTITUTE - 1.01 Articolo in rivista -
Prognostic relevance of pleural invasion for resected NSCLC patients undergoing adjuvant treatments: A propensity score-matched analysis of SEER database De Giglio A.; Di Federico A.; Gelsomino F.; Ardizzoni A. 2021-01-01 LUNG CANCER - 1.01 Articolo in rivista -
Programmed Cell Death Protein-1 Inhibitors Versus Programmed Death-Ligand 1 Inhibitors in Addition to Chemotherapy for the First-Line Treatment of Advanced NSCLC: A Systematic Review and Meta-Analysis Di Federico A.; De Giglio A.; Parisi C.; Gelsomino F.; Boni L.; Ardizzoni A. 2021-01-01 JTO CLINICAL AND RESEARCH REPORTS - 1.01 Articolo in rivista PIIS2666364321000734.pdf
Relatlimab and nivolumab in untreated advanced melanoma: insight into RELATIVITY Raschi E.; Comito F.; Massari F.; Gelsomino F. 2023-01-01 IMMUNOTHERAPY - 1.01 Articolo in rivista -
Should We Test Cancer Susceptibility Genes in Routinely Used Multigene Panels? A Case of Synchronous Lung Adenocarcinoma and Breast Cancer Associated With Germline CHEK2 Mutation Federico, Alessandro Di; Gelsomino, Francesco; De Biase, Dario; Ardizzoni, Andrea 2021-01-01 CLINICAL LUNG CANCER - 1.01 Articolo in rivista -
Single-agent carboplatin in extensive disease small-cell lung cancer patient with liver failure: A case report within the experience of a single institution Di Federico A.; Andrini E.; Sisi M.; Nuvola G.; Lamberti G.; Lenzi B.; Nobili E.; Gelsomino F.; A...rdizzoni A. 2021-01-01 ANTI-CANCER DRUGS - 1.01 Articolo in rivista acd-32-755.pdf
STK11/LKB1 and KEAP1 mutations in non-small cell lung cancer: Prognostic rather than predictive? Di Federico A.; De Giglio A.; Parisi C.; Gelsomino F. 2021-01-01 EUROPEAN JOURNAL OF CANCER - 1.01 Articolo in rivista -